Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis

被引：1

|

作者：

Abrahami, Devin

D'Andrea, Elvira

Kim, Seoyoung C.

Wexler, Deborah J.

Paik, Julie M.

Patorno, Elisabetta

机构：

来源：

DIABETES | 2022年 / 71卷

关键词：

D O I：

10.2337/db22-1145-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1145-P

引用

收藏

页数：2

相关论文

共 50 条

[21] NOT SO SWEET: EUGLYCEMIC DIABETIC KETOACIDOSIS AND SGLT2 INHIBITORS
Simonson, Michael G.
Omran, Sina Salehi
JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S524 - S524
[22] SGLT2 Inhibitors Use and Diabetic Ketoacidosis in the Inpatient Setting
Zankar, Sarah
Arnaout, Amel
DIABETES, 2023, 72
[23] SGLT2 Inhibitors and Euglycemic Ketoacidosis
Masuta, Pardeep
Johri, Geetanjali
Paul, Manju
AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (04) : E498 - E500
[24] Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
Fralick, Michael
Schneeweiss, Sebastian
Patorno, Elisabetta
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23): : 2300 - 2302
[25] SGLT2 inhibitor-related risk of diabetic ketoacidosis
Reactions Weekly, 2016, 1590 (1) : 7 - 7
[26] SGLT2 inhibitors increase risk of genital infections and ketoacidosis
Reactions Weekly, 2021, 1853 (1) : 10 - 10
[27] FEARS study: SGLT2 inhibitors associated with ketoacidosis risk
Hamann, Andreas
DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (02) : 138 - +
[28] Rate of diabetic ketoacidosis higher with new use of SGLT2 inhibitors
Reactions Weekly, 2021, 1874 (1) : 11 - 11
[29] SGLT-2 inhibitors: risk of diabetic ketoacidosis
Reactions Weekly, 2020, 1815 (1) : 10 - 10
[30] Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors
Genc, Selin
Evren, Bahri
Yigit, Onur Selcuk
Sahin, Ibrahim
Dayanan, Ramazan
Klisic, Aleksandra
Erturk, Ayse
Mercantepe, Filiz
PHARMACEUTICALS, 2024, 17 (11)

← 1 2 3 4 5 →